Logo image of CBGB.DE

CARLSBERG AS-B (CBGB.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:CBGB - DK0010181759 - Common Stock

110.1 EUR
-0.2 (-0.18%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

CBGB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 26 industry peers in the Beverages industry. While CBGB has a great profitability rating, there are quite some concerns on its financial health. CBGB is valued expensive and it does not seem to be growing. Finally CBGB also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CBGB had positive earnings in the past year.
In the past year CBGB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CBGB reported negative net income in multiple years.
CBGB had a positive operating cash flow in each of the past 5 years.
CBGB.DE Yearly Net Income VS EBIT VS OCF VS FCFCBGB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B -30B -40B

1.2 Ratios

CBGB has a Return On Assets of 5.78%. This is amongst the best in the industry. CBGB outperforms 84.62% of its industry peers.
CBGB's Return On Equity of 35.73% is amongst the best of the industry. CBGB outperforms 88.46% of its industry peers.
CBGB has a better Return On Invested Capital (8.91%) than 80.77% of its industry peers.
CBGB had an Average Return On Invested Capital over the past 3 years of 12.89%. This is significantly above the industry average of 7.67%.
Industry RankSector Rank
ROA 5.78%
ROE 35.73%
ROIC 8.91%
ROA(3y)-9.78%
ROA(5y)-3.77%
ROE(3y)-48.69%
ROE(5y)-23.03%
ROIC(3y)12.89%
ROIC(5y)11.3%
CBGB.DE Yearly ROA, ROE, ROICCBGB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

CBGB has a better Profit Margin (10.89%) than 61.54% of its industry peers.
CBGB's Profit Margin has improved in the last couple of years.
The Operating Margin of CBGB (14.12%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CBGB has remained more or less at the same level.
The Gross Margin of CBGB (45.73%) is comparable to the rest of the industry.
CBGB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.12%
PM (TTM) 10.89%
GM 45.73%
OM growth 3Y-4.19%
OM growth 5Y-1.39%
PM growth 3Y2.18%
PM growth 5Y4.04%
GM growth 3Y-1.21%
GM growth 5Y-1.54%
CBGB.DE Yearly Profit, Operating, Gross MarginsCBGB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

CBGB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CBGB has less shares outstanding
The number of shares outstanding for CBGB has been reduced compared to 5 years ago.
The debt/assets ratio for CBGB has been reduced compared to a year ago.
CBGB.DE Yearly Shares OutstandingCBGB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CBGB.DE Yearly Total Debt VS Total AssetsCBGB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

CBGB has an Altman-Z score of 1.40. This is a bad value and indicates that CBGB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.40, CBGB is doing worse than 80.77% of the companies in the same industry.
The Debt to FCF ratio of CBGB is 14.04, which is on the high side as it means it would take CBGB, 14.04 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.04, CBGB is doing worse than 80.77% of the companies in the same industry.
A Debt/Equity ratio of 2.67 is on the high side and indicates that CBGB has dependencies on debt financing.
The Debt to Equity ratio of CBGB (2.67) is worse than 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 14.04
Altman-Z 1.4
ROIC/WACC2.33
WACC3.83%
CBGB.DE Yearly LT Debt VS Equity VS FCFCBGB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

CBGB has a Current Ratio of 0.70. This is a bad value and indicates that CBGB is not financially healthy enough and could expect problems in meeting its short term obligations.
CBGB has a worse Current ratio (0.70) than 88.46% of its industry peers.
A Quick Ratio of 0.54 indicates that CBGB may have some problems paying its short term obligations.
The Quick ratio of CBGB (0.54) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
CBGB.DE Yearly Current Assets VS Current LiabilitesCBGB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

3. Growth

3.1 Past

The earnings per share for CBGB have decreased strongly by -26.75% in the last year.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
EPS 1Y (TTM)-26.75%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CBGB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.50% yearly.
The Revenue is expected to decrease by -1.86% on average over the next years.
EPS Next Y7.55%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
EPS Next 5Y8.5%
Revenue Next Year-2.58%
Revenue Next 2Y-2.06%
Revenue Next 3Y-1.48%
Revenue Next 5Y-1.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBGB.DE Yearly Revenue VS EstimatesCBGB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B 100B
CBGB.DE Yearly EPS VS EstimatesCBGB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20 40 60 80

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.19, CBGB can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CBGB is valued a bit more expensive than 76.92% of the companies in the same industry.
CBGB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.92.
CBGB is valuated rather expensively with a Price/Forward Earnings ratio of 24.98.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBGB indicates a rather expensive valuation: CBGB more expensive than 84.62% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CBGB to the average of the S&P500 Index (23.46), we can say CBGB is valued inline with the index average.
Industry RankSector Rank
PE 31.19
Fwd PE 24.98
CBGB.DE Price Earnings VS Forward Price EarningsCBGB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CBGB's Enterprise Value to EBITDA ratio is in line with the industry average.
CBGB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.67
EV/EBITDA 10.51
CBGB.DE Per share dataCBGB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBGB does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CBGB may justify a higher PE ratio.
PEG (NY)4.13
PEG (5Y)N/A
EPS Next 2Y11.68%
EPS Next 3Y10.06%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.28%, CBGB has a reasonable but not impressive dividend return.
CBGB's Dividend Yield is a higher than the industry average which is at 2.92.
CBGB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 3.28%

5.2 History

The dividend of CBGB is nicely growing with an annual growth rate of 8.19%!
Dividend Growth(5Y)8.19%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

39.92% of the earnings are spent on dividend by CBGB. This is a low number and sustainable payout ratio.
The dividend of CBGB is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP39.92%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
CBGB.DE Yearly Income VS Free CF VS DividendCBGB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10B -20B -30B -40B
CBGB.DE Dividend Payout.CBGB.DE Dividend Payout, showing the Payout Ratio.CBGB.DE Dividend Payout.PayoutRetained Earnings

CARLSBERG AS-B

FRA:CBGB (12/23/2025, 7:00:00 PM)

110.1

-0.2 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-30 2025-10-30
Earnings (Next)02-04 2026-02-04/amc
Inst Owners49.32%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap14.61B
Revenue(TTM)65.35B
Net Income(TTM)8.94B
Analysts77.93
Price Target135.04 (22.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.28%
Yearly Dividend3.62
Dividend Growth(5Y)8.19%
DP39.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.01%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.19
Fwd PE 24.98
P/S 1.33
P/FCF 20.67
P/OCF 10.16
P/B 4.36
P/tB N/A
EV/EBITDA 10.51
EPS(TTM)3.53
EY3.21%
EPS(NY)4.41
Fwd EY4%
FCF(TTM)5.33
FCFY4.84%
OCF(TTM)10.84
OCFY9.85%
SpS82.85
BVpS25.25
TBVpS-56.53
PEG (NY)4.13
PEG (5Y)N/A
Graham Number44.78
Profitability
Industry RankSector Rank
ROA 5.78%
ROE 35.73%
ROCE 11.05%
ROIC 8.91%
ROICexc 9.86%
ROICexgc 67.7%
OM 14.12%
PM (TTM) 10.89%
GM 45.73%
FCFM 6.43%
ROA(3y)-9.78%
ROA(5y)-3.77%
ROE(3y)-48.69%
ROE(5y)-23.03%
ROIC(3y)12.89%
ROIC(5y)11.3%
ROICexc(3y)15.76%
ROICexc(5y)13.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.98%
ROCE(5y)14.01%
ROICexgc growth 3Y27.92%
ROICexgc growth 5Y36.11%
ROICexc growth 3Y13.8%
ROICexc growth 5Y10.01%
OM growth 3Y-4.19%
OM growth 5Y-1.39%
PM growth 3Y2.18%
PM growth 5Y4.04%
GM growth 3Y-1.21%
GM growth 5Y-1.54%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 14.04
Debt/EBITDA 4.07
Cap/Depr 113.41%
Cap/Sales 6.66%
Interest Coverage 8.51
Cash Conversion 65.44%
Profit Quality 59.02%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.4
F-Score7
WACC3.83%
ROIC/WACC2.33
Cap/Depr(3y)105.07%
Cap/Depr(5y)101.51%
Cap/Sales(3y)6.06%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.75%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y7.55%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
EPS Next 5Y8.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-2.58%
Revenue Next 2Y-2.06%
Revenue Next 3Y-1.48%
Revenue Next 5Y-1.86%
EBIT growth 1Y9.83%
EBIT growth 3Y3.16%
EBIT growth 5Y1.2%
EBIT Next Year63.2%
EBIT Next 3Y22.73%
EBIT Next 5Y17.41%
FCF growth 1Y-18.48%
FCF growth 3Y-9.14%
FCF growth 5Y-3.87%
OCF growth 1Y0.6%
OCF growth 3Y-2.69%
OCF growth 5Y-1.56%

CARLSBERG AS-B / CBGB.DE FAQ

What is the fundamental rating for CBGB stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBGB.DE.


What is the valuation status for CBGB stock?

ChartMill assigns a valuation rating of 2 / 10 to CARLSBERG AS-B (CBGB.DE). This can be considered as Overvalued.


What is the profitability of CBGB stock?

CARLSBERG AS-B (CBGB.DE) has a profitability rating of 6 / 10.


How financially healthy is CARLSBERG AS-B?

The financial health rating of CARLSBERG AS-B (CBGB.DE) is 2 / 10.


Can you provide the expected EPS growth for CBGB stock?

The Earnings per Share (EPS) of CARLSBERG AS-B (CBGB.DE) is expected to grow by 7.55% in the next year.